TRELLUS HEALTH LS -0006 (F:85Q) — Stock Price
TRELLUS HEALTH LS -0006 (F:85Q) is currently trading at €0.00 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.02. This page tracks TRELLUS HEALTH LS -0006's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of TRELLUS HEALTH LS -0006.
TRELLUS HEALTH LS -0006 (85Q) Stock Price Chart — Daily History & Trading Volume
The chart below tracks TRELLUS HEALTH LS -0006's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
TRELLUS HEALTH LS -0006 Income Statement — Revenue, Profit & Earnings by Year
TRELLUS HEALTH LS -0006's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Revenue | €114.00K | €19.00K | €18.00K | €25.00K |
| Cost of Revenue | €0.00 | €0.00 | €0.00 | €0.00 |
| Gross Profit | €114.00K | €19.00K | €18.00K | €25.00K |
| Research & Development | — | — | — | — |
| SG&A | €3.27 Million | €1.96 Million | €3.45 Million | €1.62 Million |
| Total Operating Expenses | €8.14 Million | €6.82 Million | €8.83 Million | €5.93 Million |
| Operating Income | €-8.03 Million | €-6.80 Million | €-8.81 Million | €-5.90 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | — | — | €0.00 | €0.00 |
| Income Before Tax | €-7.78 Million | €-6.34 Million | €-8.81 Million | €-5.90 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €-7.78 Million | €-6.34 Million | €-8.81 Million | €-5.90 Million |
TRELLUS HEALTH LS -0006 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes TRELLUS HEALTH LS -0006's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Total Assets | €12.14 Million | €20.29 Million | €25.91 Million | €36.80 Million |
| Total Current Assets | €4.51 Million | €12.33 Million | €19.37 Million | €32.43 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €56.00K | — | €0.00 | €25.00K |
| Inventory | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | €371.00K | €786.00K | €822.00K | €1.52 Million |
| Total Current Liabilities | €371.00K | €786.00K | €822.00K | €1.52 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €11.77 Million | €19.50 Million | €25.09 Million | €35.27 Million |
| Retained Earnings | €-29.59 Million | €-21.81 Million | €-15.47 Million | €-6.66 Million |
TRELLUS HEALTH LS -0006 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how TRELLUS HEALTH LS -0006 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | €-7.32 Million | €-5.27 Million | €-8.62 Million | €-4.77 Million |
| Capital Expenditures | €540.00K | €2.35 Million | €2.91 Million | €3.72 Million |
| Free Cash Flow | €-7.86 Million | €-7.62 Million | €-11.53 Million | €-8.49 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | €13.00K | €24.00K | €62.00K | €139.00K |
| Depreciation | €865.00K | €716.00K | €536.00K | €32.00K |
| Change in Cash | €-7.86 Million | €-7.62 Million | €-11.53 Million | €30.02 Million |
TRELLUS HEALTH LS -0006 Earnings History — EPS Actual vs. Analyst Estimates
Track TRELLUS HEALTH LS -0006's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 01, 2026 | — | — | — |
| Sep 24, 2025 | — | — | — |
| May 12, 2025 | — | — | — |